EUCTR2012-003494-26-IT进行中（未招募）不适用
EVALUATION OF THE EFFECT OF TESTOSTERONE REPLACEMENT THERAPY ON PROSTATIC INFLAMMATION AND LOWER URINARY TRACT SYMPTOMS IN HYPOGONADAL SUBJECTS - Florence-PROTEST
AZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI0 个研究点开始时间: 2012年7月26日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •1. Adult male subjects (=18 years old) who are planned fror simple prostatectomy for BPH 2. Diagnosis of Metabolic syndrome(according to AHA/NHLBI) 3. ddiagnosis of prostatic inflammation (NIH-CPSI score >15) 4. Able to understand the study procedures and to sign informed written consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 100
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •1. Partecipation to another clinical study 2. Previous diagnosis of breast or prostatic cancer 3. PSA >4ng/mL 4. Hematocrit =52% 5. Use of 5alpha-reductase inhibitors in the previous 3 months ; 6. Psychiatruic disorders 7. Severe disease that unable the patient to partecipate to the study 8. Severe hypersensitivity to the drug
研究者
相似试验
招募中
4 期
Study of effects of testosterone replacement therapy in hypogonadal men with type 2 diabetes mellitusCTRI/2019/09/021175Dr Ronak Gandhi
进行中（未招募）
1 期
Does Testposterone improve the Pain Perception of Patients with Chronic Pain?Patient with persistent somatoform pain disorder (F45.40 or F45.41) should be included into the study.EUCTR2016-000048-32-DERWTH Aachen University/CTC-A60
招募中
Unknown
Effect of testosterone replacement associated with bariatric surgery in men with obesityObesityRBR-9qks3pcHospital e Maternidade São Domingos
进行中（未招募）
不适用
Effect of Transdermal Testosterone Replacement in Hypogonadal Men with either Metabolic Syndrome or Type 2 Diabetes Mellitus - TIMES 2Male hypogonadism is generally characterised by abnormally low serum testosterone levels. Symptoms include changes in mood, decreased bone mineral density, increased body fat, decreased muscle mass and strength and sexual dysfunction. A number of conditions can also be associated with decreased testosterone production including metabolic syndrome, type II diabetes mellitus, atherosclerosis, myocardial infarction and chronic heart failureEUCTR2005-002607-17-DEProstrakan Pharmaceuticals Ltd520
进行中（未招募）
不适用
Effect of Transdermal Testosterone Replacement in Hypogonadal Men with either Metabolic Syndrome or Type 2 Diabetes MellitusEUCTR2005-002607-17-ITSTRAKAN PHARMACEUTICALS LIMITED320